27452524|t|CD84 mediates CLL - microenvironment interactions
27452524|a|Chronic lymphocytic leukemia (CLL) is a malignant disease of small mature lymphocytes. Signals from the CLL microenvironment promote progression of the disease and induce drug resistance. This phenomenon is largely dependent on direct contact between the malignant B cells and stromal cells. CD84 belongs to the signaling lymphocyte activation molecule family of immunoreceptors, which self-associates, forming an orthogonal homophilic dimer. We therefore hypothesized that CD84 may bridge between CLL cells and their microenvironment, promoting cell survival. Our in vitro results show that CD84 expressed on CLL cells interact with CD84 expressed on cells in their microenvironment, inducing cell survival in both sides. Blocking CD84 in vitro and in vivo disrupt the interaction of CLL cells with their microenvironment, resulting in induced cell death. Thus, our findings suggest novel therapeutic strategies based on the blockade of this CD84 - dependent survival pathway.
27452524	0	4	CD84	T103	UMLS:C0666283
27452524	14	17	CLL	T038	UMLS:C0023434
27452524	37	49	interactions	T038	UMLS:C0007582
27452524	50	78	Chronic lymphocytic leukemia	T038	UMLS:C0023434
27452524	80	83	CLL	T038	UMLS:C0023434
27452524	90	107	malignant disease	T038	UMLS:C0442867
27452524	117	135	mature lymphocytes	T017	UMLS:C1513026
27452524	154	157	CLL	T038	UMLS:C0023434
27452524	183	209	progression of the disease	T038	UMLS:C0242656
27452524	221	236	drug resistance	T038	UMLS:C0013203
27452524	305	322	malignant B cells	T038	UMLS:C0079731
27452524	327	340	stromal cells	T017	UMLS:C1518246
27452524	342	346	CD84	T103	UMLS:C0666283
27452524	362	409	signaling lymphocyte activation molecule family	T103	UMLS:C4277631
27452524	413	428	immunoreceptors	T103	UMLS:C0597357
27452524	436	451	self-associates	T038	UMLS:C1819957
27452524	524	528	CD84	T103	UMLS:C0666283
27452524	548	551	CLL	T038	UMLS:C0023434
27452524	552	557	cells	T017	UMLS:C0007634
27452524	596	609	cell survival	T038	UMLS:C0007620
27452524	642	656	CD84 expressed	T038	UMLS:C1171362
27452524	660	663	CLL	T038	UMLS:C0023434
27452524	664	669	cells	T017	UMLS:C0007634
27452524	684	698	CD84 expressed	T038	UMLS:C1171362
27452524	702	707	cells	T017	UMLS:C0007634
27452524	744	757	cell survival	T038	UMLS:C0007620
27452524	782	786	CD84	T103	UMLS:C0666283
27452524	800	807	in vivo	T082	UMLS:C1515655
27452524	835	838	CLL	T038	UMLS:C0023434
27452524	839	844	cells	T017	UMLS:C0007634
27452524	895	905	cell death	T038	UMLS:C0007587
27452524	917	925	findings	T033	UMLS:C0243095
27452524	976	984	blockade	T103	UMLS:C3540676
27452524	993	997	CD84	T103	UMLS:C0666283
27452524	1010	1018	survival	T038	UMLS:C0007620
27452524	1019	1026	pathway	T038	UMLS:C1704259